Trendlines Group Ltd. March 2026 Update: Key Developments, Shareholder Information, and Potential Share Price Catalysts

Corporate Highlights

• Annual Report and Corporate Documents Released: On 11 March 2026, Trendlines Group Ltd. published its Annual Report for the financial year 2025. Alongside, the company released notices and proxy forms for both its Annual General Meeting (AGM) and a Special General Meeting (SGM), as well as a circular for the SGM. These documents provide transparency into the company’s financial health and governance, which are crucial for investor decision-making.
• Resilience in Challenging Conditions: Despite ongoing disruptions in Israel—including air raid sirens and the necessity for safe room breaks—the company and its portfolio companies report that they are “coping well” and continuing to operate as usual. This operational resilience in the face of geopolitical risk is a positive signal to investors concerned about the company’s ability to maintain business continuity.

Portfolio Company News

• IBI Ag Ltd. Achieves Key Milestone: IBI Ag Ltd., a portfolio company of Trendlines, has successfully completed its proof of concept for an AI-driven platform dedicated to the de novo design of novel bioinsecticide proteins. This technological breakthrough positions IBI Ag as a potential leader in the agri-biotech sector, targeting sustainable agricultural solutions—a sector with strong growth prospects and increasing investor interest.
• Seger Surgical Solutions Ltd. Advances Clinical Program: Seger Surgical Solutions Ltd., another Trendlines portfolio company, has successfully completed three first-in-human cases in a clinical trial for its proprietary SEGER IDEA™ laparoscopic bowel closure device. Successfully reaching this stage of clinical validation significantly reduces product development risk and enhances the company’s value proposition for future commercialisation or acquisition.

Upcoming Shareholder Events

• Annual General Meeting (AGM): The AGM for the financial year ended 31 December 2025 will be held at Suntec Singapore Convention & Exhibition Centre, 1 Raffles Boulevard, Singapore, Level 3, Room 307, on Thursday, 16 April 2026, at 10:00 a.m. (Singapore time). Shareholders are encouraged to attend or participate via proxy to stay informed on strategic decisions and governance matters.

Investor Communication and Engagement

• Stay Updated: Investors can subscribe to the Trendletter, Trendlines’ monthly newsletter, for ongoing updates. For direct access to information posted on SGXNet, including investor presentations and key announcements, the company offers an investor alerts service.

Key Points for Shareholders and Potential Price-Sensitive Information

• The completion of proof of concept for IBI Ag’s AI-driven bioinsecticide platform and Seger Surgical Solutions’ successful first-in-human cases are material milestones. Both developments could potentially drive rerating of Trendlines’ portfolio and future value creation.
• The company’s demonstrated resilience in challenging conditions and continued operational progress despite geopolitical risks may reassure investors about business continuity and management effectiveness.
• The upcoming AGM may provide further insights into strategic direction, portfolio performance, and response to current risks. Shareholder participation or close monitoring of resolutions and management commentary is advised.

Regulatory Note

The announcement has been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd. However, it has not been examined or approved by the Singapore Exchange Securities Trading Limited (SGX), which assumes no responsibility for its contents or the accuracy of statements made.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consider their own investment objectives and risk tolerance before making any investment decisions. The information herein is based on Trendlines Group’s March 2026 update and may be subject to change.

View Trendlines Historical chart here